Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0359-2027Class II

LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303

Luminex Corporation / initiated 2026-10-05 / Open, Classified

Recall record

Recall number
Z-0359-2027
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Luminex Corporation
Product
LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303
Product code
NSU Instrumentation For Clinical Multiplex Test Systems
Reason for recall
Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of bloodstream infection.
FDA root cause
Error in labeling
Action
On October 5, 2026, the firm began notifying customers via "Urgent Field Safety Notice - Medical Device Recall" letters. Consignees were informed that the current Instructions for Use for the Gram-Negative Blood Culture Assay do not adequately describe interpretation of certain positive family-level results. Specifically, when a positive family-level only result is obtained ("family-level only result" refers to a positive organism family-level detection without an accompanying genus- or species-level identification), repeat testing with the LIAISON PLEX Gram-Negative Blood Culture Assay is recommended. Absence of this instruction may increase the likelihood that certain reportable detections are not appropriately recognized by the user and may contribute to an incorrect interpretation of test results. Customers were instructed to implement the following interpretation guidance: When a positive family-level only result is obtained, repeat testing with the LIAISON PLEX BCN assay is recommended. DiaSorin is updating the Instructions for Use to include the revised guidance. Revised labeling will be provided following implementation of the labeling revision. Please contact Technical Support Services with any questions or concerns at the following phone numbers:1-877-785-2323 (U.S. and Canada); +1-512-381-4397 (Outside U.S. and Canada); 1-512-219-5114 (Fax) and email:[email protected].
Quantity in commerce
30,168 test cartridges (2,514 Kits)
Distribution
US distribution nationwide. No OUS distribution.
Product codes and lots
All lots UDI-DI pending

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0359-2027
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0359-2027Class IIOngoingVoluntary: Firm initiated